Company intelligence / Profile preview

Solid Drug Development

Geneva, Geneva, Switzerland

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Solid Drug Development is a specialized strategic consultancy and contract research organization (CRO) based in Switzerland. The company provides comprehensive support for the development of medicinal products, ranging from early-stage preclinical planning to clinical execution and regulatory submission. Their services include clinical trial design, regulatory affairs strategy, medical writing, and project management for biotech and pharmaceutical companies. Solid Drug Development focuses on optimizing the drug development process to ensure efficient transitions from the laboratory to the market.

Industry: Contract Research Organization

Beyond the preview

Go deeper on Solid Drug Development.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solid Drug Development.

Explore the full profile